MAR-RANITIDINE 300 mg
The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.
- Active substance
- Ranitidine (Ranitidine Hydrochloride)
- Strength
- 300 mg
- Form
- tablet
- ATC code
- A02BA02
- Registered in
- Canada · Marcan Pharmaceuticals Inc
- Prescription
- Prescription only
- DIN
- 02443716
Source: Drug Product Database · 2026-09-30
Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.
Listed in other countries
Bulgaria 1 matching products
| Name on the box | Strength and form | Prescription | Holder | Official record |
|---|---|---|---|---|
| Ranitidin SopharmaРанитидин Софарма | 300 mg · film - coated tablets | Prescription only | СОФАРМА АД | 20000746 |
Source: Bulgarian Drug Agency register (Изпълнителна агенция по лекарствата (BDA)) · 2026-08-01
Spain 18 matching products
| Name on the box | Strength and form | Prescription | Holder | Official record |
|---|---|---|---|---|
| RANITIDINA ALTER | 300 mg · comprimido recubierto | Prescription only | Laboratorios Alter S.A. | 63152 |
| RANITIDINA APOTEX | 300 mg · comprimido recubierto | Prescription only | Apotex Europe B.V. | 63310 |
| RANITIDINA ARAFARMA GROUP | 300 mg · comprimido recubierto | Prescription only | Arafarma Group S.A. | 63821 |
| RANITIDINA ARISTO | 300 mg · comprimido recubierto con película | Prescription only | Aristo Pharma Iberia S.L. | 70953 |
| RANITIDINA AUROVITAS | 300 mg · comprimido recubierto con película | Prescription only | Aurovitas Spain, S.A.U. | 83000 |
| RANITIDINA CINFA | 300 mg · comprimido recubierto con película | Prescription only | Laboratorios Cinfa S.A. | 62192 |
12 more names not shown. Source: CIMA — Centro de Información online de Medicamentos (Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)) · 2026-09-30 · Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA.